S Zelber–Sagi, A Kessler, E Brazowsky, M … - Clinical Gastroenterology and Hepatology, 2006 - Elsevier Background & Aims: Few controlled studies have addressed the issue of effective
medical treatment for nonalcoholic fatty liver disease (NAFLD). We herein
assessed the effect of orlistat in patients with NAFLD. Methods: We ... Cited by 87 - Related articles - All 18 versions
- ►metabolic-surgery.com [PDF] A Torquati, R Lutfi, N Abumrad, WO Richards - Journal of Gastrointestinal Surgery, 2005 - Springer Type 2 diabetes mellitus (T2DM) has a very strong association with obesity. The
aim of our study was to analyze the effects of Roux-en-Y gastric bypass (RYGB)
surgery on the glucose metabolism in morbidly obese patients with T2DM. ... Cited by 33 - Related articles - All 5 versions
- Free from Publisher FGS Toledo, AD Sniderman, DE Kelley - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Two-thirds of the cohort had fatty liver. Hepatic steatosis correlated
with serum triglycerides (r = 0.40, P < 0.01) and lower HDL cholesterol (r =
−0.31, P < 0.05). ApoB and LDL cholesterol did not, being virtually ... Cited by 31 - Related articles - BL Direct - All 5 versions
BA Swinburn, D Carey, AP Hills, M Hooper, S … - Diabetes, obesity & metabolism, 2005 - pt.wkhealth.com Methods: A double-blind, randomized, placebo-controlled, parallel study was
performed in conjunction with a fat-reduced diet and physical activity advice
for 1 year. Participants (n = 339) from eight centres in Australia and New ... Cited by 27 - Related articles - All 8 versions
JP Wilding - Diabetic Medicine, 2007 - interscience.wiley.com The recent increase in the prevalence of obesity has been associated with a
coincident rise in the prevalence of Type 2 diabetes, whereas weight loss has
been shown to decrease the risk of Type 2 diabetes. The pathophysiological ... Cited by 28 - Related articles - BL Direct - All 4 versions
CC Douglas, BA Gower, BE Darnell, F Ovalle, … - Fertility and sterility, 2006 - Elsevier To determine whether eucaloric diets either enriched with monounsaturated fatty
acids (MUFA; 17% energy) or low in carbohydrates (Low CHO; 43% energy) would
increase insulin sensitivity (Si) and decrease circulating insulin ... Cited by 24 - Related articles - All 4 versions
S Bellentani, R Dalle Grave, A Suppini, G … - Hepatology, 2008 - giorgiobedogni.it Nonalcoholic fatty liver disease (NAFLD) is systematically associated with
insulin resistance and the metabolic syndrome, where behavior therapy remains
the primary treatment, simul- taneously addressing all the clinical and ... Cited by 21 - Related articles - View as HTML - BL Direct - All 4 versions
- ►kfcpt.org [PDF] H Bays, CA Dujovne - Current atherosclerosis reports, 2006 - Springer Current guidelines recommend that weight-loss therapy should be primarily based
upon specific body mass index (BMI) cut-off limits. However, in the adipocentric
paradigm, it is acknowledged that co-morbidities, such as type 2 diabetes ... Cited by 21 - Related articles - BL Direct - All 6 versions
SB Moyers - Journal of the American Dietetic Association, 2005 - Elsevier Although a nutritionally balanced, energy-controlled diet and regular exercise
form the cornerstone of weight management, supporting therapies may include
antiobesity medications when a clinician determines that pharmacologic ... Cited by 19 - Related articles - All 17 versions
